BMJ  2008;336:109 (19 January), doi:10.1136/bmj.39458.462338.3A

Letters

Overprescribing PPIs

An old problem

The first 150 words of the full text of this article appear below.

Forgacs and Loganayagam described the problem of overprescribing proton pump inhibitors (PPIs).1 In June 2002 we wrote to many journals—and were ignored—about long term side effects being identified in general practice and surgery patients, with the then extensive, long term use of PPIs. At the time we shared an increasing number of patients with dependence on PPIs who experienced acute, severe gastritis and gastro-oesophageal reflux if they suddenly stopped or missed their PPIs; some showed refractory gastroparesis and severely delayed jejuno-ileal and colonic peristalsis when trying to reduce or stop their treatment after taking the PPI for extended periods (>3-60 months).

PPIs block the normal homoeostasis of the gastro-jejuno-ileal-colonic function (owing to their very specific, acid production blocking only, cellular-molecular actions:they block only the cellular or molecular acid production and allow secondary build up or excessive reduction of the hormones gastrin, cholecystokinin, secretin, glucagon, motilin, VIP, substance P, somatostatin, and . . . [Full text of this article]

A Breck McKay, family physician, Daryl Wall, director of surgery

1 PO Box 144, Carina, Qld 4152, Australia, 2 Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Qld 4102

mckay@bigpond.net.au


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Overprescribing proton pump inhibitors
Ian Forgacs and Aathavan Loganayagam
BMJ 2008 336: 2-3. [Extract] [Full Text] [PDF]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ